Variant report
Variant | esv3448240 |
---|---|
Chromosome Location | chr4:1086671-1086915 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000178222 | chromatin interactions |
ENSG00000251639 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs373317673 | chr4:1086680-1086681 | Weak transcription Enhancers Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs606327 | chr4:1086702-1086703 | Weak transcription Enhancers Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
3 | rs629638 | chr4:1086714-1086715 | Weak transcription Enhancers Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
4 | rs571439031 | chr4:1086748-1086749 | Weak transcription Enhancers Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs538837838 | chr4:1086754-1086755 | Weak transcription Enhancers Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs367719640 | chr4:1086763-1086764 | Weak transcription Enhancers Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs629260 | chr4:1086764-1086765 | Weak transcription Enhancers Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
8 | rs535993744 | chr4:1086772-1086773 | Weak transcription Enhancers Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs76423765 | chr4:1086777-1086778 | Weak transcription Enhancers Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs144160971 | chr4:1086778-1086779 | Weak transcription Enhancers Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs554534153 | chr4:1086802-1086803 | Weak transcription Enhancers Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs369995204 | chr4:1086827-1086828 | Weak transcription Enhancers Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs572765786 | chr4:1086839-1086840 | Weak transcription Enhancers Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs534959965 | chr4:1086863-1086864 | Weak transcription Enhancers Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs11939380 | chr4:1086871-1086872 | Weak transcription Enhancers Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Myelofibrosis | 22110671 | CNVD |
Wolf-Hirschhorn syndrome | 21549014 | CNVD |
Breast cancer | 21806811 | CNVD |
Wolf-Hirschhorn syndrome | 22283845 | CNVD |
Wolf-Hirschhorn syndrome | 16773131 | CNVD |
Mental retardation | 16773131 | CNVD |
Wolf-Hirschhorn syndrome | 22470819 | CNVD |
Wolf-Hirschhorn syndrome | 18541967 | CNVD |
sporadic birth defects | 19047251 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Retinitis pigmentosa | 18421352 | CNVD |
Wolf-Hirschhorn syndrome | 19259404 | CNVD |
Bladder cancer | 19242612 | CNVD |
Breast cancer | 19242612 | CNVD |
Congenital anomalies of the kidney and urinary tract | 19242612 | CNVD |
abnormal development | 18461090 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Wilms tumour | 21544195 | CNVD |
Melanoma | 20688739 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17603634 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Neuroblastoma | 18923191 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 17142309 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Developmental delay | 21147756 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21509527 | CNVD |
Non-syndromic sensorineural hearing loss | 22297974 | CNVD |
Breast cancer | 20932292 | CNVD |
Cancer | 20164919 | CNVD |
Type 2 diabetes | 21754918 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:1084200-1093400 | Weak transcription | Ovary | ovary |
2 | chr4:1085000-1088400 | Weak transcription | Spleen | Spleen |
3 | chr4:1085800-1088200 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
4 | chr4:1086000-1087000 | Enhancers | Liver | Liver |
5 | chr4:1086000-1087600 | Strong transcription | Pancreas | Pancrea |
6 | chr4:1086000-1098400 | Weak transcription | Lung | lung |
7 | chr4:1086200-1091400 | Weak transcription | Gastric | stomach |
8 | chr4:1086200-1098600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
9 | chr4:1086600-1087000 | Weak transcription | Fetal Muscle Leg | muscle |
10 | chr4:1086600-1087800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |